The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Kovaleva G.V.

N.A. Semashko Nizhny Novgorod Regional Clinical Hospital, Cheir of Hospital Therapy of Nizhny Novgorod State Medical Academy, Health Ministry of the Russian Federation

Sutygina T.Yu.

N.A. Semashko Nizhny Novgorod Regional Clinical Hospital, Cheir of Hospital Therapy of Nizhny Novgorod State Medical Academy, Health Ministry of the Russian Federation

Koroleva L.Yu.

N.A. Semashko Nizhny Novgorod Regional Clinical Hospital, Cheir of Hospital Therapy of Nizhny Novgorod State Medical Academy, Health Ministry of the Russian Federation

Mironov N.N.

N.A. Semashko Nizhny Novgorod Regional Clinical Hospital, Cheir of Hospital Therapy of Nizhny Novgorod State Medical Academy, Health Ministry of the Russian Federation

Case report of post-MI reccurrent left ventricular failure management with Serelaxine-recombinant human relaxin-2 (Reasanz, Novartis)

Authors:

Kovaleva G.V., Sutygina T.Yu., Koroleva L.Yu., Mironov N.N.

More about the authors

Journal: Russian Journal of Cardiology and Cardiovascular Surgery. 2015;8(5): 92‑94

DOI: 10.17116/kardio20158592-94

Read: 1241 times

Download PDF (RU)
Contact the author
Table of contents

CASE REPORT OF POST-MI RECCURRENT LEFT VENTRICULAR FAILURE MANAGEMENT WITH SERELAXINE-RECOMBINANT HUMAN RELAXIN-2 (REASANZ, NOVARTIS)
CASE REPORT OF POST-MI RECCURRENT LEFT VENTRICULAR FAILURE MANAGEMENT WITH SERELAXINE-RECOMBINANT HUMAN RELAXIN-2 (REASANZ, NOVARTIS)

To cite this article:

Kovaleva GV, Sutygina TYu, Koroleva LYu, Mironov NN. Case report of post-MI reccurrent left ventricular failure management with Serelaxine-recombinant human relaxin-2 (Reasanz, Novartis). Russian Journal of Cardiology and Cardiovascular Surgery. 2015;8(5):92‑94. (In Russ.)
https://doi.org/10.17116/kardio20158592-94

ЭндоКард
Подписка 2026 Кардиология и сердечно-сосудистая хирургия (Russian Journal of Cardiology and Cardiovascular Surgery)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Pharmacological treatment and prevention of ischemia-reperfusion syndrome in percutaneous coro­nary inte­rvention. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(2):191-200
Tube­rculous otitis media in an adolescent. Clinical case. Russian Bulletin of Otorhinolaryngology. 2024;(5):63-66
Comparative analysis of the resu­lts of treatment of gastric polyps by methods of loop electroexcision, laser and endo­scopic poly­pectomy with aspi­ration capture. Endo­scopic Surgery. 2024;(6):24-30
Black Acanthosis: Diagnosis and Treatment Issues. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(6):709-712
Clinical and epidemiological indi­cators of stroke during the COVID-19 pandemic and in the post-COVID period in the Moscow region. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12-2):5-11
Resu­lts of the All-Russian consensus conference on complications in bariatric surgery. Endo­scopic Surgery. 2025;(1):15-24
Combined treatment of patients with acute muscular tonic syndrome with dorsopathy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):70-77
Characteristics, treatment features and in-hospital mortality of patients with myocardial infa­rction over 75 years old in Russia acco­rding to the REGION-IM regi­stry. Russian Cardiology Bulletin. 2025;(1):22-38
Influence of griseofulvin on inte­stinal microbiota in the treatment of microsporia in rural children. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(2):185-190
Stress and sleep: Neurobiological aspe­cts and modern options of inso­mnia therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5-2):14-21
Abstract:

Keywords:

left ventricular failure
Serelaxine
treatment

Authors:

Kovaleva G.V.

N.A. Semashko Nizhny Novgorod Regional Clinical Hospital, Cheir of Hospital Therapy of Nizhny Novgorod State Medical Academy, Health Ministry of the Russian Federation

Sutygina T.Yu.

N.A. Semashko Nizhny Novgorod Regional Clinical Hospital, Cheir of Hospital Therapy of Nizhny Novgorod State Medical Academy, Health Ministry of the Russian Federation

Koroleva L.Yu.

N.A. Semashko Nizhny Novgorod Regional Clinical Hospital, Cheir of Hospital Therapy of Nizhny Novgorod State Medical Academy, Health Ministry of the Russian Federation

Mironov N.N.

N.A. Semashko Nizhny Novgorod Regional Clinical Hospital, Cheir of Hospital Therapy of Nizhny Novgorod State Medical Academy, Health Ministry of the Russian Federation

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.